SFL Regulatory Affairs & Scientific Communication GmbH

Tweet this page
<
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
>
Registration as it was on 08 Mar 2023
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

150,000€

Financial year: Jan 2022 - Dec 2022

Lobbyists (Full time equivalent)

1.75 Fte (5)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    SFL Regulatory Affairs & Scientific Communication GmbH   (SFL)

    EU Transparency Register

    31442479070-19 First registered on 02 Jul 2012

    Goals / Remit

    SFL Regulatory Affairs & Scientific Communication GmbH (SFL) is a leading consultancy company providing integrated solutions to pharma, biotech & medtech companies, from the bench to the marketplace, within one consultancy. SFL’s core competencies: Regulatory Affairs, Medical Affairs, Public Affairs & Regulatory Intelligence, Quality Assurance, Pharmacovigilance, Supply Chain, Market Access, Legal & Healthcare Compliance.
    SFL meets clients’ needs through every stage of the product lifecycle. Team members have a proven track record in specific areas of expertise & excellent understanding of products’ lifecycle.
    Public Affairs Services: SFL advises organizations on engaging in the EU debate to shape regulatory & policy frameworks. Our team has extensive hands-on experience & proven success in supporting clients to contribute to EU healthcare laws & policies. Our services comprise strategic & operational public affairs support, intelligence, advocacy support & association management.

    Main EU files targeted

    - EU Pharmaceutical Strategy
    - European Health Union, HERA
    - Implementation of Medical Devices Regulation and In-vitro Diagnostics Regulation
    - Orphan Medicinal Products Regulation, Pediatric Regulation and their revision
    - Revision of the EU basic pharmaceutical legislation
    - Incentives on medicinal products
    - Advanced Therapy Medicinal Products Regulation
    - Europe’s Beating Cancer Plan
    - Clinical Trials Regulation
    - European Medicines Agency policy on publication of
    clinical data for medicinal products for human use
    - Blood, tissues & cells legislation and its revision
    - Regulation on Health Technology Assessment
    - Cross-border healthcare
    - EUnetHTA
    - EU pharmacovigilance system
    - EU personalized medicine activities such as use of '-omics' technologies in the development of personalized medicine
    - Access to Medicines
    - Shortages of medicinal products
    - Horizon Europe
    - European Data Strategy, Artificial Intelligence and Cybersecurity
    - Proposals for Data Governance Act and Data Act
    - Proposal for Regulation on Artificial Intelligence
    - European Health Data Space
    - General Data Protection Regulation
    - European Green Deal
    - Circular Economy Action Plan
    - EU strategy for chemicals sustainability
    - EU industrial strategy

    Address

    Head Office
    Aeschenvorstadt 52
    Basel 4051
    SWITZERLAND
    EU Office
    Aeschenvorstadt 52
    Basel 4051
    SWITZERLAND

    Website

    http://www.sfl-services.com

  • People

    Total lobbyists declared

    5

    Employment timeLobbyists
    50%2
    25%3

    Lobbyists (Full time equivalent)

    1.75

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Professional consultancies

  • Networking

    Affiliation

    SFL is a member of Medtech & Pharma Platform (MPP).

    SFL is a member of SWISS MEDTECH.

    SFL is a member of the Round Table on Antibiotics.

    SFL is a member of the British-Swiss Chamber of Commerce.

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Advances interests of their clients

    Closed financial year

    Jan 2022 - Dec 2022

    Lobbying costs for closed financial year

    150,000€

    Major contributions in closed year

    None declared

    Clients for closed financial year

    Clients list
    NameProposalAmount
    F. Hoffmann-La Roche Ltd Our work covers widely health policies and legislation in the European Union. In addition, policies and legislations impacting conditions applicable to the establishment and running of corporations are also covered. 100,000€ - 199,999€
    Medtech & Pharma Platform (MPP) Our work as leading the Secretariat covers widely all policies and legislation relevant to combined products, i.e. products that combine drugs, devices, diagnostics and/or digital elements to fulfill a medical purpose. 50,000€ - 99,999€

    Clients for current financial year

    Clients list
    Name
    F. Hoffmann-La Roche Ltd
    Medtech & Pharma Platform (MPP)

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Other activities

    None declared

  • Meetings

    Meetings

    None declared

Download this datacard